In univariate analyses of factors affecting VEMR achievement, a P‐value of less than 0.1 presented in sex, leukocyte count, platelet count, percentage of blast, percentage of basophil, spleen size, hydroxyurea use, frontline TKI therapy, CML duration, and baseline BCR‐ABL1 transcript. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.